Bank of Montreal’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-10,173
Closed -$337K 3965
2024
Q1
$337K Sell
10,173
-2,364
-19% -$75.4K ﹤0.01% 2712
2023
Q4
$421K Buy
+12,537
New +$355K ﹤0.01% 2633
2022
Q2
Sell
-3,613
Closed -$113K 4178
2022
Q1
$113K Buy
+3,613
New +$94.6K ﹤0.01% 3620
2021
Q4
Sell
-60,227
Closed -$1.76M 3595
2021
Q3
$1.76M Buy
+60,227
New +$1.45M ﹤0.01% 2144
2021
Q2
Sell
-8,438
Closed -$171K 4057
2021
Q1
$171K Sell
8,438
-9,264
-52% -$176K ﹤0.01% 3183
2020
Q4
$299K Buy
17,702
+11,040
+166% +$146K ﹤0.01% 2998
2020
Q3
$78K Sell
6,662
-2,873
-30% -$33.8K ﹤0.01% 3220
2020
Q2
$76K Sell
9,535
-1,986
-17% -$13.3K ﹤0.01% 3224
2020
Q1
$55K Sell
11,521
-11,125
-49% -$99.4K ﹤0.01% 2856
2019
Q4
$205K Buy
22,646
+980
+5% +$7.96K ﹤0.01% 3147
2019
Q3
$156K Sell
21,666
-115,452
-84% -$828K ﹤0.01% 3059
2019
Q2
$1.09M Buy
137,118
+4,158
+3% +$49.2K ﹤0.01% 2029
2019
Q1
$1.67M Buy
132,960
+26,484
+25% +$419K ﹤0.01% 1782
2018
Q4
$2.12M Buy
106,476
+6,094
+6% +$141K ﹤0.01% 1490
2018
Q3
$2.85M Buy
100,382
+76,073
+313% +$1.81M ﹤0.01% 1475
2018
Q2
$511K Sell
24,309
-3,521
-13% -$66.6K ﹤0.01% 2331
2018
Q1
$397K Buy
27,830
+3,913
+16% +$56K ﹤0.01% 2321
2017
Q4
$294K Buy
23,917
+13,240
+124% +$187K ﹤0.01% 2519
2017
Q3
$190K Buy
10,677
+197
+2% +$4.06K ﹤0.01% 2692
2017
Q2
$266K Buy
10,480
+4,260
+68% +$102K ﹤0.01% 2509
2017
Q1
$138K Buy
6,220
+6,077
+4,250% +$117K ﹤0.01% 2657
2016
Q4
$3K Sell
143
-340
-70% -$6.7K ﹤0.01% 3826
2016
Q3
$12K Buy
483
+340
+238% +$7.95K ﹤0.01% 3504
2016
Q2
$3K Buy
+143
New +$1.96K ﹤0.01% 3840
2015
Q4
Sell
-37,200
Closed -$594K 4275
2015
Q3
$594K Buy
37,200
+27,200
+272% +$531K ﹤0.01% 1781
2015
Q2
$195K Buy
+10,000
New +$186K ﹤0.01% 2423

Other funds holding EVH

Bank of Montreal's EVH Position: Q2 2024 in Review

Bank of Montreal sold out of Evolent Health (EVH) in Q2 2024, closing a stake of 10,173 shares — an estimated $337K sold.

Bank of Montreal first reported a position in EVH in Q2 2015 and held it in 26 quarters. The position peaked at $2.85M in Q3 2018. 243 funds tracked by Wall St. Rank hold EVH as of Q2 2024.

  • Bank of Montreal reported no remaining Evolent Health position as of Q2 2024 after selling out during the quarter.
  • Bank of Montreal sold 10,173 Evolent Health shares in Q2 2024, an estimated $337K.
  • Bank of Montreal first reported a position in Evolent Health in Q2 2015 and held it in 26 quarters.
  • Bank of Montreal's Evolent Health position peaked at $2.85M in Q3 2018.
  • 243 funds tracked by Wall St. Rank held Evolent Health as of Q2 2024.

Based on Bank of Montreal's 13F filing for Q2 2024, filed 14 Aug 2024.